Hemostatic Mechanisms and MetastasisKenneth V. Honn, Bonnie F. Sloane |
Contents
IS THERE CLINICAL RELEVANCE FOR THERAPIES WHICH DISRUPT | 1 |
CHAPTER | 7 |
II | 11 |
Copyright | |
43 other sections not shown
Other editions - View all
Common terms and phrases
Acad adhesion animals anticoagulation antimetastatic arachidonic acid B16 melanoma binding Biochem Biol blood coagulation cancer cells cancer patients cancer procoagulant Cancer Res carcinoma cathepsin CB activity cell lines cell surface Chem circulating Clin clinical clotting cysteine proteinase degradation demonstrated Donati MB Dvorak effects endoperoxide endothelial cells endothelium enzyme experimental factor VII factor X factor Xa fibrin fibrin deposition fibrinogen fibrinolysis fibronectin Figure hemostatic heparin Honn KV human induced inhibition injection interactions invasion laminin Liotta lung malignant cells matrix mechanisms melanoma membrane metastasis metastatic metastatic cells metastatic potential murine nafazatrom Natl Nature London normal pathway Pearlstein PGI2 phospholipid plasma plasmin plasminogen platelet aggregation primary tumor Proc procoagulant activity prostacyclin prostaglandins protein proteolytic prothrombin release role sarcoma serine proteinases studies therapy Thromb thrombin thromboxane tissue factor tumor cells tumor growth type IV collagen vascular vesicles vessel wall vitamin vitro vivo warfarin Weiss